This Formulary has been developed by members of the Medicines Management team together with clinicians, and is endorsed by the Trust’s Drugs and Therapeutics Group.
The aim of the Formulary is to advise clinicians on evidence-based, clinically and cost-effective drug treatments. The Formulary covers those drugs commonly used in mental health, and is set out in the same way as the BNF. Drugs for physical health should follow the Formulary of the local acute or primary care service.
Drugs should be prescribed generically except for preparations where a brand should be specified because of variations in bioavailability between brands – lithium for instance. The Formulary advises on appropriate choices and links to and takes account of NICE and other national guidance, as well as alerts from NPSA (National Patient Safety Agency) and MHRA (Medicines and Healthcare products Regulatory Agency) and other relevant information.
It is recognised that on occasion non-formulary items may need to be prescribed, and in such circumstances Pharmacists may seek a rationale from prescribers, which must be documented in the clinical record. There is a list of approved unlicensed uses of licensed drugs as an appendix to the Medicines Management Policy.
The Formulary should be used in conjunction with the latest edition of the Maudsley Prescribing Guidelines.
Finally, please remember that when prescribing medication it is vital that you discuss options, alternatives and reasons for prescribing with your service user. We know that doing this will lead to better patient experience.
Dr Catherine Kinane
View the Trust Formulary at www.kmptformulary.nhs.uk